Glutathione conjugation and protein modification resulting from metabolic activation of venlafaxinein vitroandin vivo
- 2 November 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Xenobiotica
- Vol. 51 (11), 1303-1317
- https://doi.org/10.1080/00498254.2021.1946204
Abstract
Venlafaxine (VLF), an antidepressant agent, is widely used to combat major depressive disorders, particularly for the treatment of selective serotonin reuptake inhibitor-resistant depression. VLF has been shown to cause liver injury. The present study aimed to investigate the metabolic activation of VLF and explore the mechanisms of hepatotoxicity induced by VLF. One glutathione (GSH) conjugate and one cysteine conjugate were both detected in mouse and human liver microsomal incubations containing VLF and GSH or cysteine. The two conjugates were also detected in cultured mouse primary hepatocytes and bile of rats after exposure to VLF. The in vitro and in vivo studies demonstrated that VLF was metabolized to a quinone methide intermediate reactive to GSH and cysteine residues of hepatic protein. The observed protein covalent binding revealed dose-dependency. The metabolic activation of VLF was P450-dependent, and CYP3A4 was found as the predominant enzyme involved in the bioactivation process. These findings facilitate better understanding of the metabolic activation-hepatotoxicity relationship of VLF and provide chemists with information about new potential structural alerts during drug design process.Keywords
Funding Information
- National Natural Science Foundation of China (81773813, U1812403)
This publication has 30 references indexed in Scilit:
- Venlafaxine-Induced Cytotoxicity Towards Isolated Rat Hepatocytes Involves Oxidative Stress and Mitochondrial/Lysosomal DysfunctionAdvanced Pharmaceutical Bulletin, 2016
- Cytochrome P450 Mediated Bioactivation of SaracatinibChemical Research in Toxicology, 2016
- Characterization of glutathione conjugates derived from reactive metabolites of bakuchiolChemico-Biological Interactions, 2016
- Evidence for the Bioactivation of 4-Nonylphenol to Quinone Methide andortho-Benzoquinone Metabolites in Human Liver MicrosomesChemical Research in Toxicology, 2010
- In Vitro Evaluation of Potential Hepatotoxicity Induced by DrugsCurrent Pharmaceutical Design, 2010
- Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation studyAnalytical and Bioanalytical Chemistry, 2009
- Trimethoprim: Novel Reactive Intermediates and Bioactivation Pathways by Cytochrome P450sChemical Research in Toxicology, 2008
- Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality dataBMJ, 2002
- Role of Quinones in ToxicologyChemical Research in Toxicology, 2000
- O- and N-demethylation of Venlafaxine In Vitro by Human Liver Microsomes and by Microsomes from cDNA-Transfected Cells Effect of Metabolic Inhibitors and SSRI AntidepressantsNeuropsychopharmacology, 1999